News
HAYA Therapeutics Named a 2025 Technology Pioneer by the World Economic Forum
HAYA Therapeutics, a Biopôle Lausanne based startup has been selected as one of the 100 early-stage companies in the World Economic Forum’s 2025 Technology Pioneers cohort! This prestigious recognition highlights the company’s pioneering work in developing next-generation, disease-modifying precision medicines. HAYA is harnessing the power of the human genome’s dark matter to create precise RNA-based…
Read MoreAtinary and Chemspeed Partner to Launch Self-Driving Labs Powered by AI and Robotics
Atinary Technologies and Chemspeed Technologies AG have joined forces in a strategic collaboration to accelerate R&D innovation by combining artificial intelligence, robotics, and automation into fully integrated Self-Driving Labs. As a first milestone, the Atinary SDLabs no-code AI platform is now fully integrated with Chemspeed’s advanced automation systems, allowing real-time, closed-loop optimization and control.…
Read Moreten23 health Joins the “Alliance for RTU”
ten23 health joins the “Alliance for RTU” – an association to advance technical exchange for ready-to-use (RTU) containers in sterile manufacturing ten23 health, a CDTMO based in Basel and Visp,has joined the „Alliance for RTU“, an association to advance technical exchange for ready-to-use (RTU) containers in sterile manufacturing. The Alliance for RTU was formed…
Read MoreSOPHiA GENETICS Launches Podcast Series to Demystify AI in Healthcare
SOPHiA GENETICS launched a new podcast series titled Decoded, hosted by CEO Dr. Jurgi Camblong. The series aims to make complex medical technologies — from AI-powered diagnostics to liquid biopsy — accessible and understandable to healthcare professionals and the wider public. The opening episode, Liquid Biopsy Decoded, features Prof. Umberto Malapelle, Chair of the…
Read MoreSuperlab Suisse to Open at Campus Biotech in 2026
Superlab Suisse, a leading provider of next-generation lab infrastructure, has announced the opening of a fully serviced lab facility at Campus Biotech in Geneva, scheduled for January 2026. This milestone marks a significant step in the evolution of Geneva as one of the most dynamic and fast-growing life science clusters in the world. Located…
Read MoreClee Medical, ProSeed & Berninox Shine at the 2025 >>venture>> Awards
The 2025 >>venture>> Award Ceremony at ETH Zurich brought together the brightest minds of Swiss innovation, with nearly 400 startups submissions and 18 finalists celebrated across six verticals. Among the standout innovators, three Swiss Health Valley startups were awarded. In the Health & Nutrition category, Clee Medical SA, a Geneva-based, Wyss Center spinoff, earned…
Read More10th Patient Quality of Life Challenge: Five Innovative Projects Awarded
For its 10th edition, the Patient Quality of Life Challenge reaffirmed its role as a launch pad for innovation in healthcare. Five finalists were selected out of more than 150 applications. Driven by Debiopharm, La-Solution.ch, and the Inartis Foundation, the Patient Quality of Life Challenge attracted nearly 150 submissions this year. Five finalists were…
Read MoreTerapet Achieved ISO 13485:2016 certification for its Quality Management System
Terapet’s is a Geneva-based, CERN spinoff, whose proprietary technology is designed to enhance precision in nuclear medicine and radiation therapy by providing advanced imaging and radiation verification solutions. The company is currently developing systems intended to support improved diagnostic accuracy and treatment outcomes in oncology and beyond. “This certification provides a solid foundation as…
Read MoreWomen in Life Sciences in the Swiss Health Valley
The Swiss Health Valley continues to shine, thanks to the talent, leadership, and vision of extraordinary women shaping the future of medicine and science. Prof. Sophie Pautex, Head of the Department of Rehabilitation and Geriatrics and Chief Physician of the Palliative Care Service at the HUG, has received the EAPC Clinical Impact Award…
Read MoreKYLYS AESTHETICS SA secures CHF 1 Million
The Geneva-based startup and FONGIT alumni develops next-generation hyaluronic acid-based medical devices. KYLYS AESTHETICS SA, a Swiss biotech clinical stage company pioneering high-performance regenerative aesthetic solutions, proudly announces the successful closing of a CHF 1 million fundraising round by existing and new investors. This capital injection will allow the company to advance the development…
Read More